This review synthesizes preclinical evidence showing that cinnamon-derived compounds can modulate inflammation, oxidative ...

In a new study, scientists at the Max Planck Institute for Evolutionary Anthropology in Leipzig analyzed the impact of more ...

The test, developed by Astrin Biosciences, utilizes deep proteomic profiling and a machine learning classifier to identify ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...

The FDA approved T-DXd plus pertuzumab for HER2-positive metastatic breast cancer, based on DESTINY-Breast09 trial results. The combination therapy reduced disease progression or death risk by 44% ...

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population.

Siddhartha Mukherjee, oncologist and author of “The Emperor of All Maladies,” asks: What if we change what a tumor can eat?

A combination of two cannabis-derived compounds can target ovarian cancer cells while sparing healthy cells, offering early clues toward new treatment possibilities.

CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce ...

In the future, scientists could use drugs made from cannabis to fight ovarian cancer. A team of scientists testing the ...

Emerging research highlights the profound influence of the brain–gut axis and neuroendocrine signaling pathways in the development, progression, and ...